For research use only
| Cat No. | ABC-SC0105T |
| Product Type | iPSC |
| Cell Type | Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HighQC™ Human Neural Stem Cell Line supports studies of neurogenesis, neural differentiation, and regenerative modeling under defined in vitro conditions.
HighQC™ Human iPSC-Derived Neural Stem Cells are generated through the directed differentiation of human induced pluripotent stem cells (iPSCs), which were reprogrammed from human fibroblasts. These cells exhibit self-renewal capacity and multipotent differentiation potential and represent an early neural lineage suitable for a wide range of neuroscience research applications. Under appropriate culture conditions, the cells can differentiate into neurons, astrocytes, and oligodendrocytes. In vitro, they typically exhibit neuroepithelial-like morphology characterized by small, round cell bodies and maintain key characteristics of neural stem cells throughout expansion. HighQC™ Human iPSC-Derived Neural Stem Cells provide a reliable and physiologically relevant in vitro model for studying human neurodevelopment, neural differentiation, neurological disease mechanisms, neurotoxicity, and evaluating potential regenerative therapies.
| Product Code | HighQC™ Human Neural Stem Cell Line, hNSC-Line, Human Neural Stem Cell Line for Neurobiology |
| Species | Human |
| Cat.No | ABC-SC0105T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | iPSC |
HighQC™ Human iPSC-Derived Neural Stem Cells can be used to investigate human neurodevelopment, neurogenesis, synapse formation, and myelination, as well as to model the pathological mechanisms of neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. They are also suitable for compound screening, neurotoxicity assessment, and evaluating potential therapeutic candidates for neurological research.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).